LFG
STOK icon

Larson Financial Group’s Stoke Therapeutics STOK Stock Holding History

Larson Financial Group’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.81K Buy
117
+25
+27% +$820 ﹤0.01% 2726
2025
Q4 		$2.92K Sell
92
-22
-19% -$661 ﹤0.01% 2678
2025
Q3 		$2.68K Buy
114
+92
+418% +$1.58K ﹤0.01% 2591
2025
Q2 		$250 Sell
22
-16
-42% -$152 ﹤0.01% 3022
2025
Q1 		$253 Buy
+38
New +$354 ﹤0.01% 2737

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Larson Financial Group's STOK Position: Q1 2026 in Review

Larson Financial Group increased its Stoke Therapeutics (STOK) stake by 27% in Q1 2026, buying an estimated $820 and bringing the position to 117 shares worth $3.81K. The position accounts for ﹤0.01% of the portfolio, ranked #2726.

Larson Financial Group first reported a position in STOK in Q1 2025 and has held it in 5 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Larson Financial Group held 117 shares of Stoke Therapeutics worth $3.81K as of Q1 2026.
  • Larson Financial Group bought 25 Stoke Therapeutics shares in Q1 2026, an estimated $820.
  • Stoke Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2726 holding.
  • Larson Financial Group first reported a position in Stoke Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.